CIK 0000730272
- Large accelerated filer
REPLIGEN CORP
Sign in to watch- Ticker
- RGEN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 042729386
- Phone
- +1 781-449-9560
- Business address
- 41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,953,260
- in 5 filings, $6.0M under 10b5-1 plans
Net −$5,953,260. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-05 | KURIYEL RALF Senior VP, R&D | Grant or award | +5,284 | 20,062 | ||
| 2026-03-05 | KURIYEL RALF Senior VP, R&D | Grant or award · Stock Option (Right to Buy) | +5,669 | 5,669 | ||
| 2026-03-04 | KURIYEL RALF Senior VP, R&D | Grant or award | +125 | 14,820 | ||
| 2026-03-04 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −42 | $125.84 | $5K | 14,778 |
| 2026-03-02 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −923 | $124.97 | $115K | 14,695 |
| 2026-02-27 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −444 | $128.73 | $57K | 15,618 |
| 2025-03-03 | KURIYEL RALF Senior VP, R&D | Grant or award | +4,826 | 16,448 | ||
| 2025-03-03 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −386 | $155.38 | $60K | 16,062 |
| 2025-03-03 | KURIYEL RALF Senior VP, R&D | Grant or award · Stock Option (Right to Buy) | +4,542 | 4,542 | ||
| 2025-02-27 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −391 | $156.54 | $61K | 11,622 |
| 2025-02-24 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −275 | $164.74 | $45K | 12,013 |
| 2024-08-02 | KURIYEL RALF Senior VP, R&D | Sale | −6,973 | $159.36 | $1.1M | 12,288 |
| 2024-08-02 | KURIYEL RALF Senior VP, R&D | Option exercise | +175 | $86.10 | $15K | 12,463 |
| 2024-08-02 | KURIYEL RALF Senior VP, R&D | Sale | −175 | $158.85 | $28K | 12,288 |
| 2024-08-02 | KURIYEL RALF Senior VP, R&D | Option exercise · Stock Option (Right to Buy) | +175 | 0 | ||
| 2024-08-01 | KURIYEL RALF Senior VP, R&D | Sale | −4,465 | $165.67 | $740K | 19,261 |
| 2024-05-14 | KURIYEL RALF Senior VP, R&D | Shares withheld for taxes | −534 | $163.34 | $87K | 23,726 |
| 2024-03-11 | KURIYEL RALF Senior VP, R&D | Option exercise | +1,271 | $86.10 | $109K | 27,777 |
| 2024-03-11 | KURIYEL RALF Senior VP, R&D | Sale | −3,517 | $193.73 | $681K | 24,260 |
| 2024-03-11 | KURIYEL RALF Senior VP, R&D | Option exercise · Stock Option (Right to Buy) | +1,271 | 0 |
Page 1 of 3 · 52 trades